Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
In 2021, diabetes was responsible for 6.7 million deaths across the world and a healthcare expenditure of USD 966 billion
GLP-1 receptor agonists, in particular, have emerged as promising new contenders in the weight loss market due to their efficacy and relative safety
2022b;27(2):e13117
Additionally, both GLP-1 and GIP play a role in cardiovascular disease, as agonists of GLP-1 have been shown to reduce platelet activation, thus supporting a protective effect of GLP-1 against microvascular thrombosis [24]
US$ 21.16
US$ 25.93
US$ 21.27
US$ 22.29
US$ 23.78
US$ 29.35
US$ 22.54
US$ 27.00
US$ 27.79
